Get Updates

FORCE Blog

This blog will cover topics of interest that affect our community. Unless otherwise stated, the blog articles will be written by Sue Friedman, Executive Director of FORCE.

Get Involved > HBOC Community > FORCE Blog

| More

FORCE Blog

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 1,082 other subscribers

Archives

Uncategorized

February 15, 2017

Guest Blog: Join FORCEs at our 2017 HBOC Conference!

by guest blogger, Jane E. Herman When I boarded the flight for my first trip to Orlando in June 2011, my goal was not to hug Mickey Mouse or visit Cinderella’s Castle. Rather, my destination was the sixth annual Joining FORCEs Conference. Not knowing anyone who would be in attendance, I was – not unexpectedly … + read more

January 12, 2017

FORCE XRAYS Program Empowers Young Breast Cancer Survivors

Unconfuse the News with the FORCE XRAYS Program When Kimberly Jackson received a breast cancer diagnosis at the age of 32 while breastfeeding her 6-month old daughter and caring for her 3-½ year old daughter, she fell into shock. In an attempt to understand more about her diagnosis and potential treatments, she began to sort … + read more

December 31, 2016

Happy New Year HBOC Community! Happy 18th Birthday, FORCE!

Note: This post, which originally was published on 1/1/15 has been updated and reposted on 12/31/16. New Year’s is always a nostalgic time for me. Tonight at just a few seconds after the stroke of midnight, FORCE and the community we have built will turn 18! In 1999, I founded FORCE, not because I made … + read more

August 19, 2016

XRAYS: One Year of Making Sense of Cancer Headlines!

Over the past year, XRAYS has become a reliable resource for improving our readers’ understanding of breast cancer related news. Since launching on August 25, 2015, XRAYS has made sense of what can often be confusing cancer headlines; empowering cancer survivors, people at high risk for breast cancer, and their families to make better decisions … + read more

May 19, 2016

Updates in Research on Treating Hereditary Cancers

Note: This post which was originally published 08/4/15 was just updated on 05/19/16. In December 2014, the FDA approved the first targeted therapy for people with BRCA mutations. Lynparza, a type of medication known as a PARP inhibitor, was approved for women with a BRCA mutation to treat advanced ovarian, fallopian tube, or primary peritoneal cancer that has progressed after … + read more

May 7, 2016

5 Stories We Love of Strong Women & Mothers: Happy Mother’s Day

Mother’s Day 2016 kicks off National Women’s Health Week, which goes from May 8th through May 14th. This is an excellent time to celebrate all of the women who have made a difference in our lives. Although beautiful, Mother’s Day can be an emotional (and sometimes messy) day. Many of us have mothers, grandmothers and … + read more

April 18, 2016

Factors That Influence Decision-making for Genetic Testing in Women with Ovarian Cancer: Early Results from Our KNOW MORE Survey

KNOW MORE is a new campaign designed by FORCE to help women diagnosed with ovarian, fallopian tube, or primary peritoneal cancers make informed decisions about genetic counseling and testing for inherited gene mutations. We kicked off the campaign by launching a brief survey to better understand how women with ovarian and related cancers make decisions around … + read more

March 3, 2016

OlympiA: A Landmark Breast Cancer PARP Inhibitor Clinical Trial

by Sue Friedman Great progress has been made since the identification of the BRCA1 and BRCA2 genes and their link to causing breast, ovarian, pancreatic and other cancers. Over the last two decades, researchers have studied how BRCA mutations cause cancer in an effort to develop new treatments. In December 2014, Lynparza, (olaparib), a type … + read more

January 29, 2016

Mammogram Update: Latest Screening Guidelines Finalized But Not Implemented

by Lisa Schlager Few health issues have stirred as much debate as the guidelines surrounding screening mammograms for average-risk women. Recent changes in national guidelines threatened access to mammograms for women age 40-49. FORCE worked together with other groups to pass laws that assure continued access to mammograms for women in this age group. At … + read more

January 8, 2016

Value in Cancer Care: Including Consumers in the Dialogue

by Lisa Schlager, Vice President of Policy and Community Affairs Value and access to appropriate health care is of vital importance to patients and their families, particularly as cancer diagnoses continue to rise—up more than 20 percent in the past decade—and health care costs steadily increase. In this environment, more attention is being paid to … + read more

December 18, 2015

Breast Cancer is Tough Enough. Finding Credible Information About it Should Be Easy.

Knowing that you are at high risk for breast cancer, or being diagnosed with breast cancer, is never easy. Finding out that someone you know is at high risk for breast cancer or has been diagnosed with breast cancer is just as hard. Having to then try to comprehend the medical jargon that you read … + read more

September 27, 2015

Beyond Awareness: Working to Improve Outcomes for People Facing Hereditary Cancer

This week we mark National Hereditary Breast and Ovarian Cancer (HBOC) Week, and on Wednesday, National Previvor Day. This awareness campaign acknowledges the over one million people and families in the United States affected by hereditary cancer, due to a BRCA, PALB2, PTEN, ATM or other mutation linked to these cancers or a strong family history … + read more

March 31, 2015

Angelina Jolie and Patient-Centered Outcomes Research

Kudos to Angelina Jolie Pitt for sharing her BRCA status and news of her prophylactic surgeries with the world, soon after her risk-reducing mastectomy two years ago and again last week when she wrote about her bilateral salpingo-oophorectomy. Her two op-eds brought an unprecedented level of awareness about hereditary cancer, making words like “mutation” and … + read more

February 20, 2015

HBOC, FORCE, and the President’s Precision Medicine Initiative

Recently, President Obama outlined his Precision Medicine Initiative, which generated a lot of buzz. If successful, the plan will move medical research toward personalized treatment options that are based on people’s genetics, environment, lifestyle, and individual preferences. I’m excited that the White House is recognizing and committing funding towards an approach to health care research … + read more

December 19, 2014

A Game-Changing Holiday Gift for People with BRCA Mutations

Today is a landmark for the HBOC community! After almost a decade of research, AstraZeneca has received FDA approval for Lynparza (also known as olaparib) for women with BRCA mutations who have ovarian, fallopian tube or primary peritoneal cancer, and who responded favorably to their initial treatment. This is the first FDA-approved PARP inhibitor, and … + read more

Connect with others.

Call our Helpline

Our helpline offers peer support for people concerned about hereditary cancer. All calls are confidential. Call any time.

Join a Local Group

FORCE has outreach groups throughout the United States and in Essex, United Kingdom that meet periodically to offer peer support, and share resources.

FORCE:Facing Our Risk of Cancer Empowered